Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Oral BG-12 in multiple sclerosis.
Emerging role of interleukin-22 in autoimmune diseases.
Multiple sclerosis: Effect of smoking on antibody response to IFN-β treatment.
Therapy optimization: a new model for managing high-cost biologics.
Functional relevance for multiple sclerosis-associated genetic variants.
Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations.
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.
Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases.
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.
A Comparison of Supervised Machine Learning Algorithms and Feature Vectors for MS Lesion Segmentation Using Multimodal Structural MRI.
Longitudinal follow-up of vision in a neuromyelitis optica cohort.
Fully automatic detection of deep white matter T1 hypointense lesions in multiple sclerosis.
EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy.
Suicidal Behavior and Neurological Illnesses.
Oligodendrocyte progenitor cells: the ever mitotic cells of the CNS.
[Acute transverse myelitis after allogeneic bone marrow transplantation for acute lymphoblastic leukemia--a case report].
TRO19622 Promotes Myelin Repair in a rat Model of Demyelination.
Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor.
RANDOM FOREST FLAIR RECONSTRUCTION FROM T 1, T 2, AND PD -WEIGHTED MRI.
Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.
Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
Comparing two conditions of administering the six-minute walk test in people with multiple sclerosis.
A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs

Pages